Back to results
US 12,741,984 B2Granted
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
AssigneeAtea Pharmaceuticals, Inc.
InventorsAdel Moussa, Jean-Pierre Sommadossi
Life of this patent
Estimating the term…
Abstract
A hemi-sulfate salt of the structure: to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.
Claims20
A solid oral dosage form comprising a compound of the formula
- that delivers from about 100 mg to about 800 mg of the compound.
A method to treat a hepatitis C infection, in a human in need thereof, comprising administering a pharmaceutical composition comprising from about 100 mg to about 800 mg of a compound of the formula:
Dependencies are inferred from the claim text.